Skip to main content
CCAP
NASDAQ Unknown

Crescent Capital BDC Reports Significant Decline in Net Investment Income and Increased Non-Accrual Loans for 2025

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$13.27
Mkt Cap
$490.891M
52W Low
$12.7
52W High
$18.565
Market data snapshot near publication time

Summary

Crescent Capital BDC, Inc. reported a substantial year-over-year decrease in net investment income and net assets for 2025, alongside a notable increase in non-accrual portfolio companies, indicating deteriorating credit quality.


Key Events

  • Net Investment Income Decline

    Net investment income decreased to $66.9 million ($1.81 per share) in 2025 from $89.0 million ($2.40 per share) in 2024, primarily due to lower benchmark rates and restructurings.

  • Increased Non-Accrual Loans

    The number of non-accrual portfolio companies rose from 7 in 2024 to 11 in 2025, representing 4.1% of total debt investments at cost and 2.0% at fair value, indicating worsening credit quality.

  • Net Assets Decrease

    Net assets resulting from operations significantly decreased to $34.5 million in 2025 from $73.6 million in 2024.

  • NAV per Share Decline

    Net asset value per share decreased to $19.10 as of December 31, 2025, from $19.98 as of December 31, 2024.


Analysis

The annual report reveals a challenging year for Crescent Capital BDC, marked by a significant decline in profitability and a worsening credit portfolio. The substantial increase in non-accrual loans is a key concern, as it directly impacts the company's ability to generate income and could lead to further write-downs. While the company maintains an asset coverage ratio above regulatory requirements, the refinancing of debt at higher interest rates will likely put additional pressure on net investment income in future periods. Investors should closely monitor the trend in non-accrual assets and the impact of rising interest expenses on the company's ability to maintain its dividend and grow its net asset value.

At the time of this filing, CCAP was trading at $13.27 on NASDAQ in the Unknown sector, with a market capitalization of approximately $490.9M. The 52-week trading range was $12.70 to $18.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCAP - Latest Insights

CCAP
May 27, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.38
Real-time Price: $11.26 info
Change: -$0.120 (-1%) info
Market Cap: $414.885M info
CCAP
May 27, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.38
Real-time Price: $11.26 info
Change: -$0.120 (-1%) info
Market Cap: $414.885M info
CCAP
May 20, 2026, 3:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.22
Real-time Price: $11.26 info
Change: +$0.040 (+0.36%) info
Market Cap: $414.885M info
CCAP
May 13, 2026, 5:47 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.74
Real-time Price: $11.26 info
Change: -$1.48 (-12%) info
Market Cap: $414.885M info
CCAP
May 13, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.74
Real-time Price: $11.26 info
Change: -$1.48 (-12%) info
Market Cap: $414.885M info
CCAP
May 13, 2026, 5:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.07
Real-time Price: $11.26 info
Change: -$1.81 (-14%) info
Market Cap: $414.885M info
CCAP
Mar 09, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.87
Real-time Price: $11.26 info
Change: -$1.61 (-13%) info
Market Cap: $414.885M info
CCAP
Feb 25, 2026, 4:51 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $13.27
Real-time Price: $11.26 info
Change: -$2.01 (-15%) info
Market Cap: $414.885M info
CCAP
Feb 25, 2026, 2:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.12
Real-time Price: $11.26 info
Change: -$1.86 (-14%) info
Market Cap: $414.885M info